Breaking News Headlines Today | Ground News

See every side of every news story

endpoints.news image

News from endpoints.news

endpoints.news’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

endpoints.news’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about endpoints.news

Where is endpoints.news located?endpoints.news's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top endpoints.news News

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump — ANGELA WEISS/AFP via Getty Images via Getty Images

Drug Prices · United States

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

50% Center coverage: 320 sources

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.See the Story

Oral Drug Wins FDA Approval for Chronic Hives

Chatham, Virginia · Chatham

Oral Drug Wins FDA Approval for Chronic Hives

66% Center coverage: 26 sources

(MedPage Today) -- The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday. Indicated for adults with stubborn symptoms despite the use of...See the Story

Trump delays threatened 100 percent tariffs on drugs — REUTERS / pwu404

Tariffs · United States

Trump delays threatened 100 percent tariffs on drugs

62% Center coverage: 13 sources

The Trump administration is holding off on its threatened 100 percent tariffs on drugmakers that aren’t building facilities in the U.S., with officials saying the new tax is still being prepared. See the Story

Breaking News Topics Related to endpoints.news